Literature DB >> 31802674

Dynamic Alterations of Plasma Metabolites in the Progression of Liver Regeneration after Partial Hepatectomy.

Yalei Zhao, Ermei Chen1, Kaizhou Huang, Zhongyang Xie, Sainan Zhang, Daxian Wu, Feiyang Ji, Danhua Zhu, Xiaowei Xu, Lanjuan Li.   

Abstract

To elucidate the dynamic alterations of metabolites in rat plasma during liver regeneration and search for potential biomarkers of liver regeneration, 65 male Sprague-Dawley rats were divided into three groups: 70% partial hepatectomy group (PHx, n = 30), sham-operated group (Sham, n = 30), and pre-PHx group (pre-PHx, n = 5). Rats in the Sham and PHx groups were sacrificed after 30 min (min), 6 h (h), 24, 48, 72, and 168 h of surgery (n = 5 per time point). The gas chromatography-mass spectrometry-based metabolomic approach was used to identify the dynamic metabolites. Liver regeneration in the rats was evidenced by an increase in the liver weight/body weight ratio, expression of proliferating cell nuclear antigen, and yes-associated protein-1. Thirty-four differentially abundant metabolites between the Sham and PHx groups were identified, which were involved in arginine and proline metabolism, aminoacyl-tRNA biosynthesis, and cysteine and methionine metabolism pathways. Of these metabolites, low 1,5-anhydroglucitol may indicate proliferation of liver parenchymal cells during liver regeneration. Thus, a series of metabolic changes occurred with the progression of liver regeneration, and 1,5-anhydroglucitol could function as a novel hallmark of proliferation of liver parenchymal cells.

Entities:  

Keywords:  1,5-anhydroglucitol; liver regeneration; metabolomics; partial hepatectomy

Mesh:

Year:  2019        PMID: 31802674     DOI: 10.1021/acs.jproteome.9b00493

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  3 in total

1.  1,5-Anhydroglucitol Predicts Mortality in Patients with HBV-Related Acute-on-chronic Liver Failure.

Authors:  Lingjian Zhang; Yalei Zhao; Zhongyang Xie; Lanlan Xiao; Qingqing Hu; Qian Li; Shima Tang; Jie Wang; Lanjuan Li
Journal:  J Clin Transl Hepatol       Date:  2022-01-10

2.  ASF1B Serves as a Potential Therapeutic Target by Influencing Cell Cycle and Proliferation in Hepatocellular Carcinoma.

Authors:  Xiaoxi Ouyang; Longxian Lv; Yalei Zhao; Fen Zhang; Qingqing Hu; Zuhong Li; Danhua Zhu; Lanjuan Li
Journal:  Front Oncol       Date:  2022-01-11       Impact factor: 6.244

Review 3.  Understanding the Unique Microenvironment in the Aging Liver.

Authors:  Yalei Zhao; Ya Yang; Qian Li; Jianzhou Li
Journal:  Front Med (Lausanne)       Date:  2022-02-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.